StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
TYRA

Tyra Biosciences, Inc.

TYRA Nasdaq Pharmaceutical Preparations EDGAR ↗
$32.04
-1.02 -3.09%

Key statistics

from XBRL data in SEC filings
Market cap
$1.91B
Revenue (TTM)
Net income (TTM)
-$131M
EPS (TTM)
$-2.18
P/E ratio
Dividend yield
Free cash flow
-$95.3M
Cash
$85.0M
Total assets
$412M
Gross margin
52-week range
$9.96 – $40.65

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Shareholder vote results Jun 2, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release) May 13, 2026 8-K Director or officer change Apr 17, 2026 8-K Director or officer change Apr 2, 2026 8-K Other events Mar 4, 2026 10-K Fiscal year ended 2025-12-31 Mar 2, 2026 8-K Results of operations (earnings release) Mar 2, 2026 8-K Director or officer change Dec 1, 2025 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 8-K Other events Aug 22, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K Other events Jun 30, 2025 8-K Shareholder vote results May 29, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 8-K Results of operations (earnings release) Mar 27, 2025 8-K Director or officer change Jan 29, 2025 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Other events Oct 28, 2024 8-K Director or officer change; Regulation FD disclosure; Other events Oct 25, 2024 8-K Unregistered sale of equity Oct 18, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Results of operations (earnings release) Aug 7, 2024 8-K Modified rights of security holders; Amended charter or bylaws; Shareholder vote results May 31, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024 8-K Director or officer change May 7, 2024 10-K Fiscal year ended 2023-12-31 Mar 19, 2024 8-K Results of operations (earnings release) Mar 19, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Feb 5, 2024 8-K Other events Feb 1, 2024 8-K Other events Dec 22, 2023 10-Q Quarter ended 2023-09-30 Nov 7, 2023 8-K Results of operations (earnings release) Nov 7, 2023 8-K Amended charter or bylaws Oct 26, 2023